Breaking News
FONT-SIZE Plus   Neg
Share SHARE

CVC Capital Partners, ValueAct Continue To Consider Options In Respect Of Misys

Funds advised by CVC Capital Partners Ltd. and ValueAct Capital Master Fund, L.P. noted the recent announcement by Vista of its recommended cash offer for Misys Plc (MSY.L, MUSJF.PK).

Misys had announced today that it agreed to be acquired by an investment vehicle owned by US-based private equity firm Vista Equity Partners for 350 pence per share, totaling about 1.3 billion pounds.

CVC and ValueAct continue to consider their options in respect of Misys, including a possible recommended joint cash offer for the company and urge Misys shareholders to take no action at this time.

However, there can be no certainty that an offer will be made by CVC and ValueAct, nor, if made, that a deal will result.

Click here to receive FREE breaking news email alerts for Misys plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After ending the previous session modestly lower, stocks are turning in a lackluster performance in early trading on Thursday. The major averages have turned mixed on the day, with the Dow benefiting from a strong gain by shares of Visa (V). Hundreds of protesters stormed Burkina Faso's parliament on Thursday and set fire to the building, preventing the lawmakers from considering a bill to extend the president's 27-year rule. Security forces opened fire on protesters, as they looted computers and televisions in the National Assembly, news agencies reported. The angry crowd then marched towards the President's office, before they were U.S. economic activity increased by more than expected in the third quarter of 2014, according to a report released by the Commerce Department on Thursday. The Commerce Department said GDP increased by 3.5 percent in the third quarter compared to 3.0 percent growth expected by economists.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.